10.50 - 11.12
3.81 - 12.83
1.80M / 1.60M (Avg.)
158.14 | 0.07
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
2315.49%
Cost growth above 1.5x CGAU's 22.83%. Michael Burry would check for structural cost disadvantages.
-2315.49%
Gross profit decline while CGAU shows 127.37% growth. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
112.34%
G&A growth above 1.5x CGAU's 29.01%. Michael Burry would check for operational inefficiency.
-367.61%
Marketing expense reduction while CGAU shows 0.00% growth. Joel Greenblatt would examine competitive risk.
197.65%
Other expenses growth while CGAU reduces costs. John Neff would investigate differences.
163.81%
Operating expenses growth 1.25-1.5x CGAU's 123.69%. Martin Whitman would scrutinize control.
164.37%
Total costs growth above 1.5x CGAU's 43.91%. Michael Burry would check for inefficiency.
No Data
No Data available this quarter, please select a different quarter.
301.90%
D&A growth above 1.5x CGAU's 27.02%. Michael Burry would check for excessive investment.
-168.63%
EBITDA decline while CGAU shows 62.07% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
-164.37%
Operating income decline while CGAU shows 135.74% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
240.00%
Other expenses growth while CGAU reduces costs. John Neff would investigate differences.
-162.97%
Pre-tax income decline while CGAU shows 161.81% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-162.97%
Net income decline while CGAU shows 717.36% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
-89.84%
EPS decline while CGAU shows 750.00% growth. Joel Greenblatt would examine position.
-89.44%
Diluted EPS decline while CGAU shows 1600.00% growth. Joel Greenblatt would examine position.
-0.22%
Share count reduction while CGAU shows 0.09% change. Joel Greenblatt would examine strategy.
-0.22%
Diluted share reduction while CGAU shows 0.16% change. Joel Greenblatt would examine strategy.